Introduction {#Sec1}
============

Scope of Chapter {#Sec2}
----------------

The development of high-performance liquid chromatography (HPLC) packings and instrumentation over the past 25 yr has revolutionized the efficiency and speed of separation of molecules in general and peptides in particular. This development has also seen a tremendous output of published literature on the topic of HPLC of peptides, perhaps making the decision as to how best to approach a particular separation problem seem formidable to the novice, or even experienced HPLC user. Fortunately, regardless of whether high-performance approaches are utilized for routine peptide separations or for such state-of-the-art areas as proteomics, capillary methods, biospecific interactions, and so on, the fundamentals of chromatographic protocols remain the same. Thus, it is not the purpose of this chapter to present a comprehensive review of HPLC of peptides. Indeed, there is a wealth of relevant material accessible in the literature. For instance, several useful articles and reviews on HPLC of peptides can be found in **refs.** [@CR1]--[@CR4]. In addition, **refs.** [@CR5] ***--*** [@CR8] represent excellent resource books in this area. Finally, **ref.** [@CR9] offers an extensive source of information on the early development of HPLC of peptides.

This chapter is aimed at laboratory-based researchers, both experienced chromatographers and those with limited exposure to high-performance separation approaches, who wish to learn about peptide analysis by HPLC, based on representative examples from research carried out in our laboratory with general applicability. Standard analytical applications in HPLC of peptides will be stressed, together with novel approaches to separations and modest scale-up for preparative purification of peptides. In addition, the value of the complementary technique of capillary electrophoresis (CE) for peptide separations will be demonstrated. Finally, in order to maximize the "user friendliness" of this chapter, only nonspecialized columns, mobile phases, and instrumentation readily available and easily employed by the researcher are described.

Properties of Peptides and Proteins and Practical Implications {#Sec3}
--------------------------------------------------------------

### Properties of Amino Acids {#Sec4}

The side-chains of amino acids are generally classified according to their polarity, i.e., nonpolar or hydrophobic vs polar or hydrophilic. Further, the polar side-chains are divided into three main groups: uncharged polar, positively charged, or basic side-chains, and negatively charged or acidic side-chains. Within any single group, there are considerable variations in the size, shape and properties of the side-chains. Peptides containing ionizable (acidic and basic) side-chains have a characteristic isoelectric point (pI) and the overall net charge and polarity of a peptide in aqueous solution will vary with pH. Thus, hydrophilicity/hydrophobicity, as well as the number of charged groups present, become important factors in the separation of peptides. Intrinsic amino acid side-chain hydrophilicity/hydrophobicity coefficients have been recently published ([@CR10]), and these reversed-phase (RP)-HPLC derived values at pH 2.0 and pH 7.0 are shown in **Table** [1](#Tab1_1_978-1-59745-430-8){ref-type="table"}. "Intrinsic" implies the maximum possible hydrophilicity/hydrophobicity of side-chains in the absence of nearest-neighbor or conformational effects that would decrease the full expression of the side-chain hydrophilicity/hydrophobicity when the side-chain is in a polypeptide chain. Such a scale is the fundamental starting point for determining the parameters that affect side-chain hydrophobicity for quantifying such effects in peptides and proteins (e.g., the quantitative evaluation of the contribution of a specific amino side-chain to ligand--protein and protein--protein interactions and to protein folding and stability) and in aiding the development of protocols for optimum separation of polypeptides. The RP-HPLC-based approach to determining these intrinsic coefficients is described under **Subheading** [3.3.1](#Sec31){ref-type="sec"} Table 1Hydrophilicity/Hydrophobicity Coefficients Determined at 25°C by Reversed-Phase High-Performance Liquid Chromatography of Model Peptides at pH 2.0 and 7.0^a^Amino acid Substitution^b^pH 2.0^c^ $\documentclass[12pt]{minimal}
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                \begin{document}$\Delta \rm t_{R}$\end{document}$(Gly) denotes the change in retention time relative to the Gly-substituted peptide.^e^ Potentially charged residues (Asp, Glu, Arg, His, Lys, Orn) are in bold; the values between pH 2.0 and pH 7.0 that differ by more than 2 min are also in bold.

### Peptide/Protein Conformation and Stability {#Sec5}

Conformation can be an important factor in peptides as well as proteins and, thus, should always be a consideration when choosing the conditions for chromatography. Although secondary structure (e.g., $\documentclass[12pt]{minimal}
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                \begin{document}$^{a}$\end{document}$ Single amino acid substitution were made in the center of the non-polar face of model amphipathic α-helical peptide shown in **Fig.** [1](#Fig1_1_978-1-59745-430-8){ref-type="fig"}.$\documentclass[12pt]{minimal}
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                \begin{document}$^{b}$\end{document}$ ΔΔG, taken as a measure of amino acid α-helical propensity, is the difference in free energy of α-helix formation (ΔG) for each substituted amino acid residue relative to Gly **(ref.** [@CR11] **)**. Fig. 1Amino acid sequence of model amphipathic α-helical peptide used for evaluation of α-helical propensities of amino acids. **A**, Helical wheel representation; **B**, helical net representation. Amino acid substitutions were made at position X9, in the center of the nonpolar face of the α-helix. The α-helical propensities generated from this model peptide are shown in **Table** [2](#Tab1_2_978-1-59745-430-8){ref-type="table"}. (Reproduced from **ref.** [@CR11], with permission from Bentham Science.)

Interactions between hydrophobic side-chains are the most important factor in polypeptide folding and the subsequent stability of the final polypeptide conformation. Thus, knowledge of the contribution of individual amino acid side-chains in the hydrophobic core of a folded protein to peptide/protein conformation and stability is also of importance when considering the effect of the peptide/protein solubility, conformation, and interactions with the HPLC matrix during chromatography. **Table** [3](#Tab1_3_978-1-59745-430-8){ref-type="table"} lists stability coefficients of amino acids generated from single amino acid substitutions in the "a" or "d" position of the central heptad of model α-helical coiled coils (heptad positions are denoted "abcdefg," where positions "a" and "d" are the nonpolar positions responsible for the formation and stability of coiled-coils). Such coefficients allow an assessment of the effect of side-chain substitution in the hydrophobic core, as well as provide information on the effect of side-chain hydrophobicity and packing in the hydrophobic core. Although the values shown in **Table** [3](#Tab1_3_978-1-59745-430-8){ref-type="table"} were derived from a coiled-coil model ([@CR16],[@CR17]), we had previously shown that the relative contributions of nonpolar residues to protein stability in two-stranded α-helical coiled-coils showed an excellent linear correlation with the results obtained in globular proteins. In both protein types, the mutations were made in hydrophobic residues involved in the hydrophobic core, which is responsible for overall protein stability ([@CR18]). This demonstrates the general applicability of these results to proteins in general. Table 3Contribution of Amino Acid Side-Chains to Stability in the Hydrophobic Core of α-Helical Coiled-Coils3Amino acid$\documentclass[12pt]{minimal}
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                \begin{document}$^{c}$\end{document}$ A value for the Asp side-chain could not be obtained as a result of its causing unfolding of the coiled-coil, i.e., it is more destabilizing than Gly.

### Peptide Detection {#Sec6}

Peptide bonds absorb light strongly in the far ultraviolet (UV) ($\documentclass[12pt]{minimal}
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                \begin{document}$<$\end{document}$220 nm), providing a convenient means of detection (generally at 210--220 nm). In addition, the aromatic side-chains of tyrosine, phenylalanine and tryptophan absorb light in the 250--290 nm UV range; it should be noted, however, that these aromatic residues are not present in all peptides.

HPLC Modes Used in Peptide Separations {#Sec7}
--------------------------------------

The three major modes of HPLC traditionally employed in peptide separations utilize differences in peptide size (size-exclusion HPLC \[SEC\]), net charge (ion-exchange HPLC \[IEX\]), or hydrophobicity (RP-HPLC) ([@CR1] --[@CR8]). Within these modes, mobile phase conditions may be manipulated to maximize the separation potential of a particular HPLC column. In addition, a novel mixed-mode approach to peptide separation termed hydrophilic interaction chromatography (HILIC)/cation-exchange chromatography (CEX) has also shown excellent potential as a complement to RP-HPLC in recent years ([@CR19] ***--*** [@CR30]).

### HPLC Supports {#Sec8}

Silica-based packings remain the most widely used for the major modes of HPLC, the rigidity of microparticulate silica allowing the use of high flow rates of mobile phases. In addition, favorable mass transfer characteristics allow rapid analyses to be performed. Because most silica-based packings are limited to a pH range of 2.0--8.0 as a result of silica dissolution in basic eluents, high-performance column packings based on organic polymers with a broad pH tolerance (e.g., cross-linked polystyrene-divinylbenzene) are also being increasingly introduced.

### Size-Exclusion HPLC {#Sec9}

In the past, the range of required fractionation for peptides (\~100--6,000 Da) has tended toward the low end of the fractionation ability of commercial columns, designed mainly for protein separations. However, such columns have still proven useful in the early stages of a peptide purification protocol (i.e., in the early stages of a multi-step purification protocol) or for peptide/protein separations ([@CR2],[@CR17],[@CR31] ***--*** [@CR34]). The introduction of a size-exclusion column designed specifically for peptide separations (molecular weight range 100--7000) has raised the profile of this HPLC mode for peptide analysis in recent years ([@CR35]).

### Ion-Exchange HPLC {#Sec10}

IEX has proven extremely useful for peptide separations since HPLC packings capable of retaining both basic (net positive charge) or acidic (net negative charge) peptides have been introduced. Both anion-exchange (AEX) ([@CR2],[@CR3],[@CR5],[@CR8],[@CR32],[@CR36] ***--*** [@CR40]) and cation-exchange (CEX) ([@CR2],[@CR3],[@CR5],[@CR8],[@CR31],[@CR32],[@CR34],[@CR36],[@CR38],[@CR41] ***--*** [@CR45]) HPLC have been employed for peptide and protein separations, negatively charged and positively charged solutes, respectively, being retained by these ion-exchange modes. Common anion-exchange packings consist of primary, secondary, and tertiary (weak AEX) or quaternary amine (strong AEX) groups adsorbed or covalently bound to a support. These positively charged packings will interact with acidic (negatively charged) peptide residues (aspartic and glutamic acid above \~pH 4.0), as well as the negatively charged C-terminal α-carboxyl group. Common cation-exchange packings consist of carboxyl (weak CEX) or sulfonate (strong CEX) groups bound to a support matrix. These negatively charged packings will interact with the basic (positively charged) residues (histidine, pH $\documentclass[12pt]{minimal}
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                \begin{document}$< 10.0$\end{document}$), as well as the positively charged N-terminal α-amino group. Should a choice need to be made concerning the type of ion-exchange column for general peptide applications, a strong cation-exchange column is recommended. The utility of such a column lies in its ability to retain its negatively charged character in the acidic and neutral pH range, which is due to the strongly acidic sulfonate functionality characteristic of such a packing. Most peptides are soluble at low pH, where the side-chain carboxyl groups of acidic residues (glutamic acid, aspartic acid) and the free C-terminal α-carboxyl group are protonated (i.e., uncharged), thus emphasizing any basic, positively charged character of the peptides. Ion-exchange columns have proven particularly useful in a multistep protocol for peptide separations, particularly prior to a final RP-HPLC purification and desalting step.

### Reversed-Phase High-Performance Liquid Chromatography {#Sec11}

RP-HPLC remains the most widely used mode of HPLC for peptide separations ([@CR1] ***--*** [@CR8]). It is generally superior to other HPLC modes in both speed and efficiency. In addition, the availability of volatile mobile phases makes it ideal for both analytical and preparative separations. The majority of researchers have tended to carry out HPLC below pH 3.0 to take advantage of acidic volatile mobile phases (particularly aqueous trifluoroacetic acid \[TFA\]/acetonitrile \[CH$\documentclass[12pt]{minimal}
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                \begin{document}$_{3}$\end{document}$CN\] systems) ([@CR1] ***--*** [@CR8]). Such mobile phase volatility is particularly useful when carrying out preparative purification of peptides or when employing RP-HPLC as a final desalting/purification mode in a multistep protocol. Finally, acidic pH values prevent undesirable ionic interactions between positively charged amino acid residues and any underivatized silanol groups (negatively charged above pH values of 3.0--4.0) on silica-based packings ([@CR46]), still the most widely used packing support for RP-HPLC of peptides. Favored RP-HPLC packings for the vast majority of peptide separations continue to be silica-based supports containing covalently bound octyl (C$\documentclass[12pt]{minimal}
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                \begin{document}$_{18})$\end{document}$ functionalities, with peptides being eluted from these hydrophobic stationary phases in order of increasing overall peptide hydrophobicity.

### Hydrophilic Interaction/Cation-Exchange Chromatography {#Sec12}

The term "hydrophilic interaction chromatography" was originally introduced to describe separations based on solute hydrophilicity ([@CR47]), with solutes being eluted from the HILIC column in order of increasing hydrophilicity, i.e., the opposite of RP-HPLC elution behavior. This concept was taken a step further by our laboratory by taking advantage of the inherent hydrophilic character of ion-exchange, specifically strong cation-exchange, columns. Thus, HILIC/CEX combines the most advantageous aspects of two widely different separation mechanisms, i.e., a separation based on hydrophilicity/hydrophobicity differences between peptides overlaid on a separation based on net charge ([@CR19] ***--*** [@CR30]). Characteristic of HILIC/CEX separations is the presence of a high organic modifier concentration (generally, acetonitrile) to promote hydrophilic interactions between the solute and the hydrophilic/charged cation-exchange stationary phase. Peptides are then eluted from the column with a salt gradient. Generally, peptides are eluted in groups of peptides in order of increasing net positive charge. Within these groups, peptides are eluted in order of increasing hydrophilicity. Indeed, HILIC/CEX is basically CEX in the presence of high concentrations of acetonitrile (50--80%). HILIC/CEX is frequently an excellent complement to RP-HPLC. Indeed, it has rivaled or even exceeded RP-HPLC for specific peptide mixtures ([@CR4],[@CR20],[@CR27],[@CR28]).

Capillary Electrophoresis {#Sec13}
-------------------------

Although, as noted above, RP-HPLC remains the favored separation approach for peptides, CE has also proven itself as a peptide separation tool in its own right ([@CR48] ***--*** [@CR56]). CE, specifically capillary zone electrophoresis (CZE), exploits analyte charge or, more precisely, the mass-to-charge ratio. The value of these two peptide characteristics for peptide analysis in general, and peptide mapping in particular, has frequently been demonstrated ([@CR57] ***--*** [@CR59]), with RP-HPLC and CZE also proving to complement each other for a multistep approach to peptide separations ([@CR58],[@CR60] ***--*** [@CR64] ).

Materials {#Sec14}
=========

Chemical and Solvents {#Sec15}
---------------------

Water is either obtained as HPLC-grade (BDH, Poole, UK; J. T. Baker, Phillipsburg, NJ; or EMD Chemical, Gibbstown, NJ) or purified by an E-pure water filtration device from Barnstead/Thermolyne (Dubuque, IA).Reagent grade ortho-phosphoric acid (H$\documentclass[12pt]{minimal}
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                \begin{document}$_{4})$\end{document}$ is obtained from Caledon Laboratories (Georgetown, Ontario, Canada) or Anachemia (Toronto, Ontario, Canada).TFA is obtained from Hydrocarbon Products (River Edge, NJ) or Sigma-Aldrich (St. Louis, MO).Pentafluoropropionic acid (PFPA) and heptafluorobutyric acid (HFBA) are obtained from Fluka (Buchs, Switzerland) or Sigma-Aldrich.Triethylamine (TEA) is obtained from Anachemia (*see* **Note** 1).Sodium chloride (NaCl) is obtained from Sigma-Aldrich or J.T. Baker.Potassium chloride (KCl), potassium dihydrogen phosphate (KH$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$_{2}$\end{document}$PO$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$_{4})$\end{document}$, and reagent-grade urea are obtained from BDH. Extraction of UV-absorbing contaminants from analytical-grade phosphate-based buffer salts has occasionally been required. We have routinely prepared a stock solution (e.g., 1 L of 1 $\documentclass[12pt]{minimal}
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                \begin{document}$_{4})$\end{document}$ and added a chelating resin (e.g., BioRad Chelex-100; BioRad Lab, Richmond, CA), stirring for 1 h. The phosphate solution is then aliquoted, diluted as desired, and filtered through a 0.22-μm filter. Reagent-grade urea (much cheaper than highly purified urea) may be purified to a level suitable for HPLC in a straightforward procedure: following preparation of a concentrated urea solution (often 6 $\documentclass[12pt]{minimal}
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                \begin{document}${\it M}$\end{document}$ range), the solution is stirred over a mixed-bed resin (e.g., BioRad AG 501-X8, 20 to 50 mesh) (10 g/L of solution) for 30--60 min; the resin is then removed by filtration through a sintered glass funnel and the supernatant subsequently filtered through a 0.22-μm filter.Sodium perchlorate (NaClO$\documentclass[12pt]{minimal}
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                \begin{document}$_{3}$\end{document}$CN) is obtained from Fisher Scientific (Pittsburgh, PA) or EM Science (Gibbstown, NJ).Dithioerythritol (DTE) is obtained from Fisher Scientific.

Columns and Capillaries {#Sec16}
-----------------------

Except where stated otherwise, all column packings are based on microparticulate silica supports.

### Size-Exclusion HPLC {#Sec17}

*Column 1:* Superdex Peptide HR 10/30 (300 $\documentclass[12pt]{minimal}
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                \begin{document}$\times$\end{document}$ 10 mm inner diameter \[ID\]; non-silica-based support; separation range of 100--7000; Pharmacia Biotech, Baie d-Urf'e, Quebec, Canada). This column (and Columns 2 and 3) are fast protein liquid chromatography (FPLC) columns from Pharmacia with stationary phases packed into glass rather than stainless steel columns. Such columns work excellently well on HPLC equipment (as opposed to FPLC equipment) if column pressure restrictions are noted.*Column 2:* Superdex 75 HR 10/30 (300 $\documentclass[12pt]{minimal}
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### Ion-Exchange HPLC {#Sec18}

*Column 3:* Mono S HR 5/5 strong CEX column (50 $\documentclass[12pt]{minimal}
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                \begin{document}$\times$\end{document}$ 2.1 mm ID; 5 μm particle size, 300 Å pore size; PolyLC, Columbia, MD).

### Reversed-Phase HPLC {#Sec19}
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                \begin{document}$\times$\end{document}$ 2.1 mm ID; 5 μm, Å 100; Hichrom, Berkshire, UK).*Column 6:* Zorbax Eclipse XDB-C$\documentclass[12pt]{minimal}
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                \begin{document}$\times$\end{document}$ 2.1 mm I.D.; 5 μm, 80 Å; Agilent Technologies, Little Falls, DE); "XDB" denotes "extra dense bonding," these columns being designed to be particularly stable at neutral pH and above ([@CR65],[@CR66]), where dissolution of the silica matrix at neutral and (particularly) higher pH values has been previously problematic.*Column 7:* Zorbax SB300-C$\documentclass[12pt]{minimal}
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                \begin{document}$_{8}$\end{document}$, in this case) and silanol groups of the silica matrix from hydrolysis ([@CR67],[@CR68]).*Column 8:* Zorbax SB300-C$\documentclass[12pt]{minimal}
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                \begin{document}$\times$\end{document}$ 9.4 mm ID; 6.5 μm, 300 Å; Agilent Technologies).

### Capillary Electrophoresis {#Sec20}

*Capillary 1:* Uncoated capillaries of 60.2 cm $\documentclass[12pt]{minimal}
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                \begin{document}$\times$\end{document}$ 50 μm ID (50 cm effective length, i.e., length from injection point to detection point) are provided by Beckman-Coulter (Fullerton, CA).

Instrumentation {#Sec21}
---------------

### HPLC {#Sec22}

*Instrument 1:* The majority of analytical HPLC runs were carried out on an Agilent 1100 Series liquid chromatograph from Agilent Technologies.*Instrument 2:* Older runs were carried out on a Varian Vista Series 5000 liquid chromatograph (Varian, Walnut Creek, CA) coupled to a Hewlett-Packard (Avondale, PA) HP1040A detection system, disc drive, HP2225A Thinkjet printer and HP7460A plotter.*Instrument 3:* Preparative HPLC runs were carried out on a Beckman-Coulter instrument, comprised of a System Gold 126 Solvent Module and a System Gold 166 Detector.

### Capillary Electrophoresis {#Sec23}

*Instrument 4:* CE runs were carried out on a Beckman-Coulter Capillary Electrophoresis System controlled by 32 karat software (Version 5.0).

Methods {#Sec24}
=======

Size-Exclusion HPLC {#Sec25}
-------------------

Aqueous SEC is generally employed for peptide/protein separations and/or molecular weight determinations. Unique tertiary or quaternary structures can be demonstrated by molecular weight determinations in the presence and absence of denaturants in SEC ([@CR17],[@CR35]). Such applications require ideal SEC behavior, i.e., separations should be based solely on solute size. However, most modern high-performance SEC columns are anionic (i.e., carry a negative charge) to a greater or lesser extent ([@CR69]). Such a property may lead to interaction with positively charged side-chains in peptides and proteins unless such undesirable electrostatic interactions are suppressed. Because electrostatic effects are minimized above an eluent ionic strength of about 0.05 $\documentclass[12pt]{minimal}
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                \begin{document}${\it M}$\end{document}$ salts are commonly employed as the mobile phase for SEC of peptides and proteins ([@CR2],[@CR3],[@CR5],[@CR8],[@CR69]). Of course, peptide--protein or protein--protein interactions may be eliminated if the salt concentration is too high when electrostatic interactions are a dominating factor to the interaction. A mixture of five model synthetic peptide standards (10, 20, 30, 40, and 50 residues) with negligible secondary structure was developed both to detect nonideal retention behavior during SEC as well as to monitor suppression of such nonideal behavior with addition of salts ([@CR69]). Different column materials can exhibit dramatically different amounts of nonideal behavior. These SEC peptide standards can be obtained from the Alberta Peptide Institute, University of Alberta, Edmonton, Alberta, Canada.

### SEC of Peptides {#Sec26}

**Figure** [2](#Fig1_2_978-1-59745-430-8){ref-type="fig"} (top panel) shows the elution profile of six peptides containing 4, 6, 8, 10, 14, and 20 residues on a Superdex Peptide column (Column 1) and Instrument 2.Fig. 2Size-exclusion chromatography of small peptides. Column and conditions described under **Subheading** [3.1.1](#Sec26){ref-type="sec"}. **Top**, elution profile of peptides; **bottom**, relationship between Log$\documentclass[12pt]{minimal}
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                \begin{document}$_{\rm d}$\end{document}$ (distribution coefficient; *see* text in **Subheading** [3.1.1](#Sec26){ref-type="sec"}. for calculation). The sequences of the peptides are FIPK (4 residues); Ac-GGTAGG-amide (6 residues); PQSPESVD-amide (8 residues); LKAETEALKA (10 residues); Ac-TDDPASPQSPESVD-amide (14 residues); and IEALKCEIEALKAEIEALKA-amide (20 residues). (Adapted from **ref.** [@CR35], with permission from Elsevier Science.)The peptides are separated by isocratic elution with 50 m$\documentclass[12pt]{minimal}
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                \begin{document}${\it M}$\end{document}$ KCl at a flow rate of 0.5 mL/min and room temperature.The excellent resolution of the six peptides illustrates the value of this column for small peptide separations. In addition, an initial fractionation of complex peptide mixtures by this column should simplify subsequent IEX and/or RP-HPLC steps.**Figure** [2](#Fig1_2_978-1-59745-430-8){ref-type="fig"} (bottom panel) shows the linear relationship between peptide size (number of residues) and distribution coefficient (K$\documentclass[12pt]{minimal}
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### SEC Analysis of Peptide Oligomerization {#Sec27}

**Table** [4](#Tab1_4_978-1-59745-430-8){ref-type="table"} presents sequences of native regions and analogs of regions within the SARS-Coronavirus Spike S glycoprotein that form coiled-coil structures ([@CR70]). Table 4Size Exclusion/High Performance Liquid Chromatography Analysis of Peptide Oligomerization State4Peptide nameOligomerization stateSequence^b^MWRetention time (min)HRC 1150--1185monomer*a d a d a d a d a d*Ac-D[I]{.ul}SG[I]{.ul}NAS[V]{.ul}VN[I]{.ul}QKE[I]{.ul}DR[L]{.ul}NEVAKN[L]{.ul}NES[L]{.ul}ID[L]{.ul}QEL-amide4050HRN 916--950monomer*d a d a d a d a d a*Ac-[I]{.ul}QES[L]{.ul}TT [S]{.ul}TA[L]{.ul}GK[L]{.ul}QDV[V]{.ul}NQNAQA[L]{.ul}NT[L]{.ul}VKQ[L]{.ul}SS-amide375653.6HRN 916--950 (T923I, N937I)dimerAc-[I]{.ul}QES[L]{.ul}TT[I]{.ul}STA[L]{.ul}GK[L]{.ul}QDV[V]{.ul}NQ[I]{.ul}AQA[L]{.ul}NT[L]{.ul}VKQ[L]{.ul}SS-amide753448.2HRN with linker $\documentclass[12pt]{minimal}
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                \begin{document}$d$\end{document}$ in the hydrophobic core of the coiled-coil are underlined.HRN 916--950 and HRC 1150--1185 represent native sequences within the coiled-coils (where HRN and HRC denote heptad repeat regions) at the N- and C-termini of a domain within the coronavirus S fusion protein.The linker is attached to the native HRN sequence via a Cys-Gly-Gly spacer extension at the N-terminal of the HRN 916--950 sequence. The linker and this HRN sequence are mixed at a molar ratio of 1:4 in phosphate-buffered saline at pH 7.0, followed by incubation at room temperature for 4 h during which a covalent bond is formed between the sulfhydryl group in the Cys side-chain of the peptide and the bromoacetyl groups in the linker, producing a three-stranded peptide. DTE (5 m$\documentclass[12pt]{minimal}
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                \begin{document}${\it M}$\end{document}$) is then added to the reaction mixture and incubated at room temperature for 10 min, resulting in reduction of any disulfide-bridged peptides. The three-stranded peptide and monomeric peptides are subsequently separated by RP-HPLC and the three-stranded peptide (denoted as "HRN with linker" in **Table** [4](#Tab1_4_978-1-59745-430-8){ref-type="table"}) characterized by mass spectrometry.In **Table** [4](#Tab1_4_978-1-59745-430-8){ref-type="table"}, the peptide denoted HRN 916--950 (T923I, N937I) represents an analog of the native HRN sequence whereby Thr-923 and Asn-937 have been replaced by Ile in the hydrophobic core of the coiled-coil sequence.In **Table** [4](#Tab1_4_978-1-59745-430-8){ref-type="table"}, HRN extended (902--950) represents the HRN 916--950 native sequence with the inclusion of two more native heptad sequences at the N-terminus.The peptides in **Table** [4](#Tab1_4_978-1-59745-430-8){ref-type="table"} are subjected to SEC on a Superdex 75 column (Column 2 on Instrument 1) by isocratic elution with 50 m$\documentclass[12pt]{minimal}
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Ion-Exchange HPLC {#Sec28}
-----------------

The retention time of a peptide in either AEX or CEX will depend on a number of factors including buffer pH and the nature and ionic strength of the anion or cation employed for displacement of acidic (negatively charged) or basic (positively charged) peptides, respectively. Most ion-exchange separations are carried out using sodium or potassium ion as the cationic counterion and chloride ion as the anionic counterion. High-performance IEX packings tend to exhibit hydrophobic characteristics to varying degrees, perhaps resulting in significant peak broadening or even nonelution of peptides due to undesirable interactions with nonpolar residues in the peptide, which can be suppressed through the addition of an organic modifier (generally, 10--20% CH$\documentclass[12pt]{minimal}
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### Monitoring of Peptide Chain Length Effects on CEX Using Synthetic Peptide Standards {#Sec29}

Two series of synthetic, positively charged peptide standards were subjected to CEX on a Mono S strong cation-exchange column (Column 3 on Instrument 2): a series of four 11-residue cation-exchange standards with net charges of $\documentclass[12pt]{minimal}
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Reversed-Phase HPLC {#Sec30}
-------------------

In the authors' experience, the best approach to most analytical peptide separations is to employ aqueous TFA to TFA/CH$\documentclass[12pt]{minimal}
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### Determination of Intrinsic Hydrophilicity/Hydrophobicity of Amino Acid Side-Chains by RP-HPLC of Model Peptides {#Sec31}

A model peptide sequence is designed for quantitation of amino acid side-chain hydrophilicity/hydrophobicity in the absence of nearest-neighbor or conformational effects: Ac-X-G-A-K-G-A-G-V-G-L-amide, where X is substituted by the 20 amino acids plus norvaline ($\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$n$\end{document}$-Val), norleucine ($\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$n$\end{document}$-Leu) and ornithine (Orn) ([@CR10]).The peptides are eluted from a Kromasil C$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$_{18}$\end{document}$ column (Column 5 on Instrument 1) at pH 2.0 by a linear AB gradient (0.25% CH$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$_{3}$\end{document}$CN/min) at a flow-rate of 0.3 mL/min and a temperature of 25°C, where eluent A is 20 m$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}${\it M}$\end{document}$ aqueous TFA, pH 2.0 containing 2% acetonitrile, and eluent B is 20 m$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}${\it M}$\end{document}$ TFA in CH$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$_{3}$\end{document}$CN (**Fig.** [5A](#Fig1_5_978-1-59745-430-8){ref-type="fig"}). Some "wetting" of the stationary phase, particularly highly hydrophobic and high-ligand-density phases such as the Kromasil C$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$_{18}$\end{document}$ packing, is occasionally required to ensure reproducible results.Fig. 5Determination of intrinsic hydrophilicity/hydrophobicity of amino acid side-chains by reversed-phase high-performance liquid chromatography of model peptides. Column and conditions shown in **Subheading** [3.3.1](#Sec31){ref-type="sec"}. A, pH 2.0 elution profile; **B**, pH 7.0 elution profile; **C**, correlation of amino acid side-chain coefficients obtained at pH 2.0 vs pH 7.0. Peptide sequences shown under **Subheading** [3.3.1](#Sec31){ref-type="sec"}.These same peptides are eluted from a Zorbax XDB-C$\documentclass[12pt]{minimal}
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### Effect of Anionic Ion-Pairing Reagent Hydrophobicity on Selectivity of Peptide Separations {#Sec32}
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### Effect of Temperature on RP-HPLC of Peptides {#Sec33}

The effect of temperature on the elution behavior of a mixture of nine synthetic random coil peptides is shown in **Fig.** [7](#Fig1_7_978-1-59745-430-8){ref-type="fig"}.Fig. 7Effect of temperature on reversed-phase high-performance liquid chromato-graphy of peptides ($\documentclass[12pt]{minimal}
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                \begin{document}$+3$\end{document}$ net charge). Column and conditions described under **Subheading** [3.3.3](#Sec33){ref-type="sec"}. Peptide sequences shown in **Table** [6](#Tab1_6_978-1-59745-430-8){ref-type="table"}. Table 6Sequences of Two-dimensional Cation-Exchange/Reversed-Phase Chromatography Peptide Standards6Peptide StandardNet ChargeChange in Carbon atom ContentPeptide SequenceMassChange in Mass1a+10Ac-Gly-Gly-Gly-Gly-Gly-Leu-Gly-Leu-Gly-Lys-amide81401b+11Ac-Gly-Gly-**Ala**-Gly-Gly-Leu-Gly-Leu-Gly-Lys-amide828141c+12Ac-Gly-Gly-**Ala-Ala**-Gly-Leu-Gly-Leu-Gly-Lys-amide842281d+13Ac-Gly-Gly-**Val**-Gly-Gly-Leu-Gly-Leu-Gly-Lys-amide856421e+14Ac-Gly-Gly-**Val-Ala**-Gly-Leu-Gly-Leu-Gly-Lys-amide870561f+14Ac-Gly-Gly-**Ile**-Gly-Gly-Leu-Gly-Leu-Gly-Lys-amide870561g+15Ac-Gly-Gly-**Ile-Ala**-Gly-Leu-Gly-Leu-Gly-Lys-amide884701h+17Ac-Gly-Gly-**Ile-Val**-Gly-Leu-Gly-Leu-Gly-Lys-amide912981i+18Ac-Gly-Gly-**Ile-Ile**-Gly-Leu-Gly-Leu-Gly-Lys-amide9261122a+20Gly-Gly-Gly-Gly-Gly-Leu-Gly-Leu-Gly-Lys-amide77202b+21Gly-Gly-**Ala**-Gly-Gly-Leu-Gly-Leu-Gly-Lys-amide786142c+22Gly-Gly-**Ala-Ala**-Gly-Leu-Gly-Leu-Gly-Lys-amide800282d+23Gly-Gly-**Val**-Gly-Gly-Leu-Gly-Leu-Gly-Lys-amide814422e+24Gly-Gly-**Val-Ala**-Gly-Leu-Gly-Leu-Gly-Lys-amide828562f+24Gly-Gly-**Ile**-Gly-Gly-Leu-Gly-Leu-Gly-Lys-amide828562g+25Gly-Gly-**Ile-Ala**-Gly-Leu-Gly-Leu-Gly-Lys-amide842702h+27Gly-Gly-**Ile-Val**-Gly-Leu-Gly-Leu-Gly-Lys-amide870982i+28Gly-Gly-**Ile-Ile**-Gly-Leu-Gly-Leu-Gly-Lys-amide8841123a+30Gly-Gly-Gly-Gly-Lys-Leu-Gly-Leu-Gly-Lys-amide84303b+31Gly-Gly-**Ala**-Gly-Lys-Leu-Gly-Leu-Gly-Lys-amide857143c+32Gly-Gly-**Ala-Ala**-Lys-Leu-Gly-Leu-Gly-Lys-amide871283d+33Gly-Gly-**Val**-Gly-Lys-Leu-Gly-Leu-Gly-Lys-amide885423e+34Gly-Gly-**Val-Ala**-Lys-Leu-Gly-Leu-Gly-Lys-amide899563f+34Gly-Gly-**Ile**-Gly-Lys-Leu-Gly-Leu-Gly-Lys-amide899563g+35Gly-Gly-**Ile-Ala**-Lys-Leu-Gly-Leu-Gly-Lys-amide913703h+37Gly-Gly-**Ile-Val**-Lys-Leu-Gly-Leu-Gly-Lys-amide941983i+38Gly-Gly-**Ile-Ile**-Lys-Leu-Gly-Leu-Gly-Lys-amide955112Ac denotes α-acetyl; amide denotes Cα-amide. Standards in the $\documentclass[12pt]{minimal}
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### Effect of Temperature on RP-HPLC of Random Coil vs α-Helical Peptides {#Sec34}

**Figure** [8](#Fig1_8_978-1-59745-430-8){ref-type="fig"} compares the RP-HPLC separation of random coil and α-helical [l]{.smallcaps}- or [d]{.smallcaps}-peptides around the optimum temperatures for overall separation of the peptide mixtures ([@CR76]).Fig. 8Effect of temperature on reversed-phase high-performance liquid chromato-graphy of random coil vs α-helical peptides. The subscript R and H denote random coil and helical peptides, respectively. Column, conditions, and peptide sequences described under **Subheading** [3.3.4](#Sec34){ref-type="sec"}. (Reproduced from **ref.** [@CR76], with permission from Elsevier Science.The synthetic random coil peptides have the sequence Ac-X-L-G-A-K-G-A-G-V-G-amide, where X is substituted with the 19 [l]{.smallcaps}- and [d]{.smallcaps}-amino acids and Gly.The synthetic amphipathic α-helical peptides have the sequence Ac-E-A-E-K-A-A-K-E-X-E-K-A-A-K-E-A-E-K-amide, where X is substituted with the 19 [l]{.smallcaps}- and [d]{.smallcaps}-amino acids and Gly.Mixtures of the peptides are subjected to RP-HPLC on a Zorbax SB300-C$\documentclass[12pt]{minimal}
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HILIC/CEX {#Sec35}
---------

It is important to note that different ion-exchange packings exhibit differing degrees of hydrophobic characteristics ([@CR42]). In order to gain the full benefit of peptide separations by the HILIC mode in mixed-mode HILIC/CEX, it is important to overcome unwanted hydrophobic properties of the matrix with as low a level of organic modifier (CH$\documentclass[12pt]{minimal}
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### HILIC/CEX of Proteomic Peptide Standards {#Sec36}

HILIC/CEX is applied to the separation of a mixture of three groups of synthetic model peptides designed as two-dimensional CEX/RP-HPLC peptide standards, i.e., proteomics standards (**Table** [6](#Tab1_6_978-1-59745-430-8){ref-type="table"}): $\documentclass[12pt]{minimal}
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Capillary Electrophoresis {#Sec39}
-------------------------

As noted above (**Subheading** [3.4.1](#Sec36){ref-type="sec"}.), a mixture of 27 peptides is designed as synthetic proteomic peptide standards. These peptides are comprised of three groups of nine 10-residue peptides (with net charges of $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$+1$\end{document}$, $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$+2$\end{document}$, and $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$+3$\end{document}$ for all nine peptides within a group), the hydrophobicity of the nine peptides within a group varying only subtly between adjacent peptides. The sequences and characteristics of the peptide standards are shown and described in **Table** [6](#Tab1_6_978-1-59745-430-8){ref-type="table"} and under **Subheading** [3.4.1](#Sec36){ref-type="sec"}.**Figure** [12](#Fig1_12_978-1-59745-430-8){ref-type="fig"} shows the RP-HPLC separation of the peptide standards on a Zorbax SB300-C$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$_{8}$\end{document}$ column (Column 8 on Instrument 1) obtained by a linear AB gradient (0.5% CH$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$_{3}$\end{document}$CN/min) at a flow rate of 0.3 mL/min and a temperature of $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$70^\circ{\rm C}$\end{document}$, where eluent A is 20 m$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}${\it M}$\end{document}$ aqueous TFA, pH 2.0, and eluent B is 20 m$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}${\it M}$\end{document}$ TFA in 80% (v/v) aqueous CH$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$_{3}$\end{document}$CN.Fig. 12Reversed-phase high-performance liquid chromatography of proteomic peptide standards. Column and conditions described under **Subheading** [3.5](#Sec13){ref-type="sec"}. Peptide sequences shown in **Table** [6](#Tab1_6_978-1-59745-430-8){ref-type="table"}. (Adapted from **ref.** [@CR56], with permission from Elsevier Science.)The conditions for RP-HPLC (an efficient ion-pairing reagent, relatively shallow gradient, high temperature, small packing particle size of 3.5 μm) are designed to optimize the separation. However, despite the reasonably satisfactory analytical elution profile, just 13 out of 27 peptides are well resolved. It is unlikely that this unidimensional approach to the separation of the peptides can be optimized further to achieve complete (or even near complete) resolution of all 27 peptides.**Figure** [13](#Fig1_13_978-1-59745-430-8){ref-type="fig"} shows the separation of the 27 peptides by CE in analogous conditions to that of RP-HPLC (i.e., with aqueous TFA as the background electrolyte \[BGE\] in the absence or presence of CH$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$_{3}$\end{document}$CN, albeit in the absence of a hydrophobic surface (uncoated capillary).Fig. 13Capillary zone electrophoresis of proteomic peptide standards. Capillary and conditions described under **Subheading** [3.5](#Sec13){ref-type="sec"}. Peptide sequences shown in **Table** [6](#Tab1_6_978-1-59745-430-8){ref-type="table"}. (Reproduced from **ref.** [@CR56], with permission from Elsevier Science.)Conditions for CE in **Fig.** [13](#Fig1_13_978-1-59745-430-8){ref-type="fig"}: uncoated capillary (Capillary 1 on Instrument 4); BGE of 10 m$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}${\it M}$\end{document}$ aqueous TFA, adjusted to pH 2.0 with LiOH, with or without 25% (v/v) CH$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$_{3}$\end{document}$CN; applied voltage, 25 kV (direct polarity) with 5-min voltage ramp; temperature, $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$15^\circ{\rm C}$\end{document}$; UV absorption at 195 nm.As shown in **Fig.** [13](#Fig1_13_978-1-59745-430-8){ref-type="fig"}, both in the absence (top panel) and presence (bottom panel) of 25% CH$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$_{3}$\end{document}$CN, the peptides are separated according to their charge-to-mass ratio (capillary zone electrophoresis (CZE) mechanism), each peak representing nine co-migrated peptides. The mobility of these three groups of peptides is according to net charge, i.e., as expected, the $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$+3$\end{document}$ group migrates faster than the $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$+2$\end{document}$ group, which migrates faster than the $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$+1$\end{document}$ group.**Figure** [13](#Fig1_13_978-1-59745-430-8){ref-type="fig"} represents a unidimensional CE separation, where peptide separation is achieved/optimized via a single peptide property (charge) and via a single charge-based mechanism (CZE). This laboratory believes that the introduction of a hydrophobicity-based mechanism, to produce a bidimensional separation, would enable an effective peptide separation.The 27 peptides were again subjected to CE under the following conditions: BGE of 0.4 $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}${\it M}$\end{document}$ aqueous TFA, PFPA, or HFBA, adjusted to pH 2.0 with LiOH; remaining conditions as above.As shown in **Fig.** [14](#Fig1_14_978-1-59745-430-8){ref-type="fig"}, an excellent separation of the 27 peptides is now achieved, with increasing ion-pairing reagent hydrophobicity (TFA $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$<$\end{document}$ PFPA $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$<$\end{document}$ HFBA) resulting in improved resolution.Fig. 14Ion-interaction capillary zone electrophoresis of proteomic peptide standards. Capillary and conditions described under **Subheading** [3.5](#Sec13){ref-type="sec"}. Peptide sequences shown in **Table** [6](#Tab1_6_978-1-59745-430-8){ref-type="table"}. (Reproduced from **ref.** [@CR56], with permission from Elsevier Science.)These separations represent bidimensional separations: peptides of the same length but different nominal charge are separated in order of decreasing charge (i.e., $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$+3$\end{document}$ peptides migrate the earliest and $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$+1$\end{document}$ peptides migrate the last) according to a CZE mechanism; within each group of peptides, the peptides are separated in order of increasing hydrophobicity according to a hydrophobically mediated mechanism introduced by the anionic ion-pairing reagent, i.e., within each charged group of peptides, the most hydrophobic peptide is eluted last and the most hydrophilic peptide is eluted first., analogous to that seen in RP-HPLC **(Fig.** [7](#Fig1_7_978-1-59745-430-8){ref-type="fig"}).This novel CE approach has been termed ion-interaction (II)CZE and is clearly superior to RP-HPLC (**Fig.** [12](#Fig1_12_978-1-59745-430-8){ref-type="fig"}) for separation of these peptide standards. This CE approach also exhibits a much larger peak capacity than RP-HPLC, as seen by the large distance between the $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$+2$\end{document}$ and $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$+1$\end{document}$ peptide groups, where peptides of different charge-to-mass ratios could be located.It should be noted that only one pair of peptides with identical charge-to-mass ratios (denoted 1e/1f) was not resolved in the presence of 0.4 $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}${\it M}$\end{document}$ HFBA. However, two other peptide pairs with identical charge-to-mass ratios (one pair in each of the $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$+2$\end{document}$ and $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$+3$\end{document}$ peptides; 2e/2f and 3e/3f, respectively) are resolved under these conditions, a significant achievement when one considers that such separations were hitherto believed impossible.Interestingly, as noted previously **(Subheading** [3.4.1](#Sec36){ref-type="sec"}.), the best overall resolution of the peptides within each group is achieved by HILIC/CEX. The high peak capacity of the II-CZE and HILIC/CEX approaches, coupled with their excellent resolution capabilities, again highlight their useful complementarity (and often superior separative effectiveness) to the ubiquitous RP-HPLC mode.

Preparative HPLC of Synthetic Peptides and Recombinant Proteins {#Sec40}
---------------------------------------------------------------

The excellent resolving power and separation time of RP-HPLC, coupled with the availability of volatile mobile phases, has made this HPLC mode the favored method for preparative separations of peptides. Also, most researchers would likely wish to carry out both analytical and preparative peptide separations on analytical equipment and columns no longer than 250 mm and no larger diameters than 10 mm ID, avoiding the prohibitively expense scale-up costs in terms of equipment, larger columns and solvent consumption. It has long been a goal of this laboratory to develop novel one-step purification schemes to avoid loss of product yield frequently a feature of multistep protocols (e.g., SEC followed by IEX and RP-HPLC).
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                \begin{document}$_{3}$\end{document}$CN gradient begins, the rule of thumb is to start 12% below that required to elute the peptide in the 1% gradient run. Thus, the gradient for the preparative run is 0 to 30% acetonitrile at 1% acetonitrile/min (30% is 12% below 42%), then begin the gradient of 0.1% CH$\documentclass[12pt]{minimal}
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                \begin{document}$_{3}$\end{document}$CN per min for 30 min to wash the remaining hydrophobic impurities off the column.Fractions are collected every 2 min and fraction analysis carried out under the same conditions described for **Fig.** [15](#Fig1_15_978-1-59745-430-8){ref-type="fig"}. Fractions are repooled as hydrophilic impurities, pure product and hydrophobic impurities (**Fig.** [16A](#Fig1_16_978-1-59745-430-8){ref-type="fig"}, **B**, and **C**, respectively). These three pools are then lyophilized, redissolved in water (10 mL) and reanalyzed by RP-HPLC (5 μL sample volumes; same conditions as described for **Fig.** [15](#Fig1_15_978-1-59745-430-8){ref-type="fig"}).**Figure** [16](#Fig1_16_978-1-59745-430-8){ref-type="fig"} shows the excellent product purity and yield obtained by this slow gradient approach to purification of the 200-mg sample load **(Fig.** [16B](#Fig1_16_978-1-59745-430-8){ref-type="fig"}). Very little product is found in the hydrophilic fraction **(Fig.** [16 A](#Fig1_16_978-1-59745-430-8){ref-type="fig"}) and hydrophobic fraction **(Fig.** [16 C](#Fig1_16_978-1-59745-430-8){ref-type="fig"}).Fig. 16Pooled fractions following reversed-phase (RP)-high-performance liquid chromatography (HPLC) purification of 100 mg of crude synthetic 26-residue amphipathic $\documentclass[12pt]{minimal}
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                \begin{document}$\alpha$\end{document}$-helical antimicrobial peptide. Column, conditions, and peptide sequence described under **Subheading** [3.6.1](#Sec41){ref-type="sec"}. Analytical RP-HPLC elution profiles of pooled fractions: **(A)** pool of all fractions containing hydrophilic impurities, **(B)** pool of all fractions containing pure product, denoted P, and (**C)** pool of all fractions containing hydrophobic impurities.**Figure** [17](#Fig1_17_978-1-59745-430-8){ref-type="fig"} illustrates fraction analyses of adjacent fractions at the beginning and end of product appearance for both the 100 mg (top panels) and 200 mg (bottom panels) sample amounts. Note that only one fraction for each sample amount contained overlapping product and hydrophilic impurities (Fr. 63 and Fr. 54 for 100-mg and 200-mg runs, respectively) or overlapping product and hydrophobic impurities (Fr. 75 and Fr. 71 for 100-mg and 200-mg runs, respectively), underlying the effectiveness of this slow gradient approach for resolution of desired peptide product from even closely structurally related synthetic impurities.Fig. 17Fraction analysis of adjacent fractions at beginning and end of product appearance following preparative reversed-phase (RP)-high-performance liquid chromatography (HPLC) of 100 mg **(top panels)** and 200 mg **(bottom panels)** of synthetic 26-residue amphipathic $\documentclass[12pt]{minimal}
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                \begin{document}$\alpha$\end{document}$-helical antimicrobial peptide. Column, conditions of preparative RP-HPLC and fraction analysis, and peptide sequence described under **Subheading** [3.6.1](#Sec41){ref-type="sec"}. P denotes desired product.It should be noted that the greater the sample load, the sooner the appearance of desired peptide product eluted from the column, i.e., Fr. 54 for a 200-mg load vs Fr. 63 for a 100-mg load. In addition, the larger the load, the greater the number of fractions needed for product elution (13 fractions for the 100 mg load and 18 fractions for the 200-mg load).The RP-HPLC column has the capacity for an even larger sample load than 200 mg. However, there is not sufficient material available to determine the maximum load on this column.

### Preparative One-Step Purification of a Recombinant Protein From a Whole Cell Lysate {#Sec42}
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                \begin{document}$\alpha$\end{document}$-tropomyosin (denoted Tm1-99) is prepared as fusion protein containing a T7 tag (14 amino acids in length) at the N-terminus ([@CR84]).The construct is inserted into a pET3a vector and the fusion protein is subsequently overexpressed in *Escherichia coli.*Following cell lysis, the cell contents are extracted with 0.1% aqueous TFA.**Figure** [18](#Fig1_18_978-1-59745-430-8){ref-type="fig"} (top) presents an analytical RP-HPLC elution profile of the cell lysate. This profile is obtained on a Zorbax SB300-C$\documentclass[12pt]{minimal}
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                \begin{document}$_{3}$\end{document}$CN/min) at a flow rate of 0.3 mL/min and room temperature, where eluent A is 0.05% aqueous TFA, pH 2.0, and eluent B is 0.05% TFA in CH$\documentclass[12pt]{minimal}
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                \begin{document}$_{3}$\end{document}$CN.Fig. 18One-step preparative reversed-phase (RP)-high-performance liquid chromatography (HPLC) purification of a recombinant protein from a whole cell lysate. **Top**, analytical RP-HPLC profile of crude sample mixture. Bottom: pooled fractions following preparative purification of recombinant protein Tm 1--99. Column, conditions of analytical RP-HPLC, preparative RP-HPLC, and fraction analysis described under **Subheading** [3.6.2](#Sec42){ref-type="sec"}. P denotes desired product. (Reproduced from **ref.** [@CR84], with permission from Elsevier Science.)As shown in **Fig.** [18](#Fig1_18_978-1-59745-430-8){ref-type="fig"} (top), the desired Tm1-99 product represented 3.2% of total contents of crude sample.A sample volume of 4 mL is applied to a Zorbax SB300-C$\documentclass[12pt]{minimal}
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                \begin{document}$_{3}$\end{document}$CN) at a flow rate of 0.3 mL/min and room temperature, where eluent A is 0.05% aqueous TFA, pH 2, and eluent B is 0.05% TFA in CH$\documentclass[12pt]{minimal}
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                \begin{document}$_{8}$\end{document}$ column (Column 7 on Instrument 1) under the same conditions as for the analytical profile of the crude cell lysates (**Fig.** [18](#Fig1_18_978-1-59745-430-8){ref-type="fig"}, top), save for a linear AB gradient of 2% CH$\documentclass[12pt]{minimal}
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                \begin{document}$_{3}$\end{document}$CN/min.The fractions are pooled into hydrophilic impurities (**Fig.** [18](#Fig1_18_978-1-59745-430-8){ref-type="fig"}, bottom left), purified product (**Fig.** [18](#Fig1_18_978-1-59745-430-8){ref-type="fig"}, bottom middle), and hydrophobic impurities (**Fig.** [18](#Fig1_18_978-1-59745-430-8){ref-type="fig"}, bottom right). These analytical profiles are obtained with the same column and conditions as the crude analytical profile (**Fig.** [18](#Fig1_18_978-1-59745-430-8){ref-type="fig"}, top).As shown in **Fig.** [18](#Fig1_18_978-1-59745-430-8){ref-type="fig"}, the purified product had a purity of \<95% and a yield of \<90% recovery. This was in contrast with a 64% purity of Tm1-99 obtained by a one-step antibody affinity approach at one-tenth the recovery of the one-step RP-HPLC approach. Scale up of the affinity approach to produce enough semi-pure material (still requiring the final RP-HPLC step) of comparable purity and yield of the RP-HPLC-based protocol alone would certainly be prohibitively expensive.Note that the same rule of thumb for the shallow gradient approach of 0.1% CH$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$_{3}$\end{document}$CN/min (as described for the 26-residue peptide **(Subheading** [3.6.1](#Sec41){ref-type="sec"}.) can be applied to the preparative purification of larger polypeptides and proteins.

### Alternative Preparative RP-HPLC Purification Approaches on Analytical Columns and Instrumentation {#Sec43}

The slow gradient approach to preparative RP-HPLC of peptides and proteins described under **Subheadings** [3.6.1](#Sec41){ref-type="sec"}. and [3.6.2](#Sec42){ref-type="sec"}. produces excellent yields of purified samples. Indeed, we recommend this simple one-step RP-HPLC protocol for routine purification of relatively small sample quantities. However, for larger scale applications, where it is of particular importance to maximize, for cost purposes, yield of purified material per gram of RP-HPLC stationary phase, we wish to direct readers to our novel preparative approach termed sample displacement chromatography (SDC), characterized by the major separation process generally taking place in the absence of organic modifier concomitant with optimum utilization of RP-HPLC column capacity ([@CR85] ***--*** [@CR89]).

#### One-Step SDC of Peptides {#Sec44}

Conventional reversed-phase SDC is conceived as a novel purification approach on high-performance analytical columns and instrumentation, where the only variable is sample load, i.e., without the addition of organic modifier or displacer (the latter being characteristic of traditional displacement chromatography ([@CR90])) to the mobile phase ([@CR85] ***--*** [@CR89]).Because peptides favor an adsorption-desorption mechanism of interaction with a hydrophobic stationary phase, under normal analytical load conditions an organic modifier is typically required for their elution from a reversed-phase column. However, when such a column is subjected to high loading of a peptide mixture dissolved in a 100% aqueous mobile phase, e.g., 0.1% aqueous TFA, there is competition by the sample components for the adsorption sites on the reversed-phase sorbent, resulting in solute--solute displacement during washing with 100% aqueous mobile phase. A more hydrophobic peptide component competes more successfully for these sites than a less hydrophobic component, which is thus displaced ahead of the more hydrophobic solute, i.e., the sample components acts as their own displacers.The SDC approach is thus simply an application of the well established general principles of displacement chromatography without the need for a separate displacer. This mode of operation, a hybrid scheme of frontal chromatography followed by elution, is characterized by a marked reduction in solvent consumption, minimal elution volumes, and the collection of fewer fractions for product isolation than in conventional RP-HPLC, with consequence reductions in time and handling.Several successful SDC separations have been reported ([@CR85] ***--*** [@CR89]), including the purification of a therapeutically important synthetic peptide representing part of the sequence of luteinizing hormonereleasing hormone (LHRH) ([@CR88]).SDC has also been adapted to modular solid-phase extraction (SPE) technology for development of a rapid, simple and cost-effective procedure for the efficient and parallel purification of multiple peptide mixtures ([@CR91]).An interesting application of anion-exchange chromatography in sample displacement mode for protein purification has also been reported ([@CR92]).

#### Two-Step SDC of Peptides {#Sec45}

SDC methodology has been developed further to carry out preparative separations on analytical equipment and columns (15 cm in length) for sample loads $\documentclass[12pt]{minimal}
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                \begin{document}$\leq$\end{document}$200 mg ([@CR93]).Following sample loading of 10- or 11-residue bradykinin antagonists in 100% aqueous solvent (e.g., 0.05% aqueous TFA) at a concentration of 7--10 mg/mL (sample loads varying from 67 mg to 200 mg) onto a small C$\documentclass[12pt]{minimal}
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                \begin{document}$_{3}$\end{document}$CN concentration displaces hydrophilic impurities off the column; the second (higher) CH$\documentclass[12pt]{minimal}
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                \begin{document}$_{3}$\end{document}$CN concentration displaces pure product from the column. Hydrophobic impurities remain trapped on the column.This modified SDC approach promises to allow great flexibility in purifying peptides, at high yield of pure product (\<99% purity), and encompassing a range of sample hydrophobicities and sample loads.

Notes {#Sec46}
=====

Although highly pure TEA can be readily purchased, the authors' laboratory has regularly used lesser-grade reagent (following distillation over ninhydrin, where necessary) with no discernible problems.Occasionally, it has been necessary to remove UV-absorbing contaminants from reagent-grade NaClO$\documentclass[12pt]{minimal}
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                \begin{document}$_{4}$\end{document}$ by passing a stock solution of the salt through a preparative (e.g., 1 cm ID) RP-HPLC column (following filtration through a 0.22-μm filter).The unusually high concentration of acetonitrile (40%) is required to eliminate nonideal behavior because of the considerable hydrophobic characteristics of the column packing. Other CEX packings are available that are hydrophilic and require considerably less acetonitrile or no acetonitrile in the mobile phase. In general, it is preferable to have each HPLC mode utilize just a single mechanism, i.e., ion-exchange mechanism only, in the absence of any nonspecific hydrophobic interactions which could complicate interpretation of results.Fifty percent of all $\documentclass[12pt]{minimal}
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                \begin{document}$\alpha$\end{document}$-helices in proteins are amphipathic ([@CR77]).In a similar manner to the effect of the hydrophobic environment characteristic of RP-HPLC in inducing helical structure in potential $\documentclass[12pt]{minimal}
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                \begin{document}$\alpha$\end{document}$-helical peptides, the presence of a high concentration (70% in this case) of organic modifier in HILIC/CEX will also induce such structure.
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